Abstract
BackgroundThere are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, a known pathological process of FTD, but has yet to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have